Akkermansia muciniphila (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Akkermansia muciniphila" in English language version.

refsWebsite

Global rank English rank

4^th place

4^th place

2^nd place

2^nd place

5^th place

5^th place

18^th place

17^th place

102^nd place

76^th place

485^th place

440^th place

1,248^th place

1,104^th place

234^th place

397^th place

1pendulumlife.com

low place

low place

low place

low place

acs.org (Global: 1,248^th place; English: 1,104^th place)

pubs.acs.org

Marcus DM, Kabat EA, Schiffman G (March 1, 1964). "Immunochemical Studies on Blood Groups. XXXI. Destruction of Blood Group A Activity by an Enzyme from Clostridium tertium Which Deacetylates N-Acetylgalactosamine in Intact Blood Group Substances*". Biochemistry. 3 (3): 437–443. doi:10.1021/bi00891a023. ISSN 0006-2960. PMID 14158532.

doi.org (Global: 2^nd place; English: 2^nd place)

Zhang T, Li Q, Cheng L, et al. (November 2019). "Akkermansia muciniphila is a promising probiotic". Microbial Biotechnology. 12 (6): 1109–1125. doi:10.1111/1751-7915.13410. ISSN 1751-7915. PMC 6801136. PMID 31006995.
Derrien M (2004). "Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium". International Journal of Systematic and Evolutionary Microbiology. 54 (5): 1469–1476. doi:10.1099/ijs.0.02873-0. PMID 15388697.
de Vos W (2017). "Microbe Profile: Akkermansia muciniphila: a conserved intestinal symbiont that acts as the gatekeeper of our mucosa". Microbiology. 1635 (5): 646–648. doi:10.1099/mic.0.000444. PMID 28530168.
Everard A, Belzer C, Geurts L, et al. (May 28, 2013). "Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity". Proceedings of the National Academy of Sciences of the United States of America. 110 (22): 9066–9071. Bibcode:2013PNAS..110.9066E. doi:10.1073/pnas.1219451110. PMC 3670398. PMID 23671105.{{cite journal}}: CS1 maint: overridden setting (link)
Dao MC, Everard A, Aron-Wisnewsky J, et al. (March 2016). "Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology". Gut. 65 (3): 426–436. doi:10.1136/gutjnl-2014-308778. hdl:10044/1/24139. PMID 26100928.{{cite journal}}: CS1 maint: overridden setting (link)
Luo Y, Lan C, Li H, et al. (October 17, 2022). "Rational consideration of Akkermansia muciniphila targeting intestinal health: advantages and challenges". npj Biofilms and Microbiomes. 8 (1): 81. doi:10.1038/s41522-022-00338-4. ISSN 2055-5008. PMC 9576740. PMID 36253412.{{cite journal}}: CS1 maint: overridden setting (link)
Aggarwal V, Sunder S, Verma SR (December 1, 2022). "Disease-associated dysbiosis and potential therapeutic role of Akkermansia muciniphila, a mucus degrading bacteria of gut microbiome". Folia Microbiologica. 67 (6): 811–824. doi:10.1007/s12223-022-00973-6. ISSN 1874-9356. PMC 9122250. PMID 35596115.
Garcia-Vello P, Tytgat HL, Elzinga J, et al. (September 27, 2024). "The lipooligosaccharide of the gut symbiont Akkermansia muciniphila exhibits a remarkable structure and TLR signaling capacity". Nature Communications. 15 (1): 8411. Bibcode:2024NatCo..15.8411G. doi:10.1038/s41467-024-52683-x. ISSN 2041-1723. PMC 11436972. PMID 39333588.
Lerouge I, Vanderleyden J (March 1, 2002). "O-antigen structural variation: mechanisms and possible roles in animal/plant–microbe interactions". FEMS Microbiology Reviews. 26 (1): 17–47. doi:10.1111/j.1574-6976.2002.tb00597.x. ISSN 0168-6445. PMID 12007641.
Raimondi S, Musmeci E, Candeliere F, et al. (May 27, 2021). "Identification of mucin degraders of the human gut microbiota". Scientific Reports. 11 (1): 11094. Bibcode:2021NatSR..1111094R. doi:10.1038/s41598-021-90553-4. ISSN 2045-2322. PMC 8159939. PMID 34045537.
Marcus DM, Kabat EA, Schiffman G (March 1, 1964). "Immunochemical Studies on Blood Groups. XXXI. Destruction of Blood Group A Activity by an Enzyme from Clostridium tertium Which Deacetylates N-Acetylgalactosamine in Intact Blood Group Substances*". Biochemistry. 3 (3): 437–443. doi:10.1021/bi00891a023. ISSN 0006-2960. PMID 14158532.
Matsuura M (May 24, 2013). "Structural Modifications of Bacterial Lipopolysaccharide that Facilitate Gram-Negative Bacteria Evasion of Host Innate Immunity". Frontiers in Immunology. 4: 109. doi:10.3389/fimmu.2013.00109. ISSN 1664-3224. PMC 3662973. PMID 23745121.
Plovier H, Everard A, Druart C, et al. (January 2017). "A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice". Nature Medicine. 23 (1): 107–113. doi:10.1038/nm.4236. ISSN 1546-170X. PMID 27892954.
Bae M, Cassilly CD, Liu X, et al. (August 2022). "Akkermansia muciniphila phospholipid induces homeostatic immune responses". Nature. 608 (7921): 168–173. Bibcode:2022Natur.608..168B. doi:10.1038/s41586-022-04985-7. ISSN 1476-4687. PMC 9328018. PMID 35896748.
Ouwerkerk JP, van der Ark KC, Davids M, et al. (December 1, 2016). "Adaptation of Akkermansia muciniphila to the Oxic-Anoxic Interface of the Mucus Layer". Applied and Environmental Microbiology. 82 (23): 6983–6993. Bibcode:2016ApEnM..82.6983O. doi:10.1128/AEM.01641-16. PMC 5103097. PMID 27663027.
Iwaza R, Wasfy RM, Dubourg G, et al. (2022). "Akkermansia muciniphila: The state of the art, 18 years after its first discovery". Frontiers in Gastroenterology. 1 1024393. doi:10.3389/fgstr.2022.1024393. ISSN 2813-1169.
Shuoker B, Pichler MJ, Jin C, et al. (April 1, 2023). "Sialidases and fucosidases of Akkermansia muciniphila are crucial for growth on mucin and nutrient sharing with mucus-associated gut bacteria". Nature Communications. 14 (1): 1833. doi:10.1038/s41467-023-37533-6. ISSN 2041-1723. PMC 10067855. PMID 37005422.
van Passel MW, Kant R, Zoetendal EG, et al. (March 3, 2011). "The Genome of Akkermansia muciniphila, a Dedicated Intestinal Mucin Degrader, and Its Use in Exploring Intestinal Metagenomes". PLOS ONE. 6 (3) e16876. Bibcode:2011PLoSO...616876V. doi:10.1371/journal.pone.0016876. PMC 3048395. PMID 21390229.
Turck D, Bohn T, Castenmiller J, et al. (September 2021). "Safety of pasteurised Akkermansia muciniphila as a novel food pursuant to Regulation (EU) 2015/2283". EFSA Journal. 19 (9): e06780. doi:10.2903/j.efsa.2021.6780. PMC 8409316. PMID 34484452.
Davoutis E, Gkiafi Z, Lykoudis PM (May 16, 2024). "Bringing gut microbiota into the spotlight of clinical research and medical practice". World Journal of Clinical Cases. 12 (14): 2293–2300. doi:10.12998/wjcc.v12.i14.2293. PMC 11099419. PMID 38765739.
Zhou K (June 2017). "Strategies to promote abundance of Akkermansia muciniphila, an emerging probiotics in the gut, evidence from dietary intervention studies". Journal of Functional Foods. 33: 194–201. doi:10.1016/j.jff.2017.03.045. ISSN 1756-4646. PMC 6223323. PMID 30416539.
de Vos WM (2017). "Microbe Profile: Akkermansia muciniphila: a conserved intestinal symbiont that acts as the gatekeeper of our mucosa". Microbiology. 163 (5): 646–648. doi:10.1099/mic.0.000444. ISSN 1465-2080. PMID 28530168.
Tian R, Yu L, Tian F, et al. (May 7, 2024). "Effect of inulin, galacto-oligosaccharides, and polyphenols on the gut microbiota, with a focus on Akkermansia muciniphila". Food & Function. 15 (9): 4763–4772. doi:10.1039/d4fo00428k. ISSN 2042-650X. PMID 38590256.
Portincasa P, Khalil M, Graziani A, et al. (January 2024). "Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations? (Review)". European Journal of Internal Medicine. 119: 13–30. doi:10.1016/j.ejim.2023.10.002. PMID 37802720.
Ajab SM, Zoughbor SH, Labania LA, et al. (2024). "Microbiota composition effect on immunotherapy outcomes in colorectal cancer patients: A systematic review". PLOS ONE. 19 (7) e0307639. Bibcode:2024PLoSO..1907639A. doi:10.1371/journal.pone.0307639. PMC 11268651. PMID 39047017.
Gu ZY, Pei WL, Zhang Y, et al. (December 5, 2021). "Akkermansia muciniphila in inflammatory bowel disease and colorectal cancer". Chinese Medical Journal. 134 (23): 2841–2843. doi:10.1097/CM9.0000000000001829. ISSN 0366-6999. PMC 8667969. PMID 34711719.
Kim S, Lee Y, Kim Y, et al. (March 18, 2020). "Akkermansia muciniphila Prevents Fatty Liver Disease, Decreases Serum Triglycerides, and Maintains Gut Homeostasis". Applied and Environmental Microbiology. 86 (7): e03004–19. Bibcode:2020ApEnM..86E3004K. doi:10.1128/AEM.03004-19. PMC 7082569. PMID 31953338.

ejinme.com (Global: low place; English: low place)

Portincasa P, Khalil M, Graziani A, et al. (January 2024). "Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations? (Review)". European Journal of Internal Medicine. 119: 13–30. doi:10.1016/j.ejim.2023.10.002. PMID 37802720.

handle.net (Global: 102^nd place; English: 76^th place)

hdl.handle.net

Dao MC, Everard A, Aron-Wisnewsky J, et al. (March 2016). "Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology". Gut. 65 (3): 426–436. doi:10.1136/gutjnl-2014-308778. hdl:10044/1/24139. PMID 26100928.{{cite journal}}: CS1 maint: overridden setting (link)

harvard.edu (Global: 18^th place; English: 17^th place)

ui.adsabs.harvard.edu

Everard A, Belzer C, Geurts L, et al. (May 28, 2013). "Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity". Proceedings of the National Academy of Sciences of the United States of America. 110 (22): 9066–9071. Bibcode:2013PNAS..110.9066E. doi:10.1073/pnas.1219451110. PMC 3670398. PMID 23671105.{{cite journal}}: CS1 maint: overridden setting (link)
Garcia-Vello P, Tytgat HL, Elzinga J, et al. (September 27, 2024). "The lipooligosaccharide of the gut symbiont Akkermansia muciniphila exhibits a remarkable structure and TLR signaling capacity". Nature Communications. 15 (1): 8411. Bibcode:2024NatCo..15.8411G. doi:10.1038/s41467-024-52683-x. ISSN 2041-1723. PMC 11436972. PMID 39333588.
Raimondi S, Musmeci E, Candeliere F, et al. (May 27, 2021). "Identification of mucin degraders of the human gut microbiota". Scientific Reports. 11 (1): 11094. Bibcode:2021NatSR..1111094R. doi:10.1038/s41598-021-90553-4. ISSN 2045-2322. PMC 8159939. PMID 34045537.
Bae M, Cassilly CD, Liu X, et al. (August 2022). "Akkermansia muciniphila phospholipid induces homeostatic immune responses". Nature. 608 (7921): 168–173. Bibcode:2022Natur.608..168B. doi:10.1038/s41586-022-04985-7. ISSN 1476-4687. PMC 9328018. PMID 35896748.
Ouwerkerk JP, van der Ark KC, Davids M, et al. (December 1, 2016). "Adaptation of Akkermansia muciniphila to the Oxic-Anoxic Interface of the Mucus Layer". Applied and Environmental Microbiology. 82 (23): 6983–6993. Bibcode:2016ApEnM..82.6983O. doi:10.1128/AEM.01641-16. PMC 5103097. PMID 27663027.
van Passel MW, Kant R, Zoetendal EG, et al. (March 3, 2011). "The Genome of Akkermansia muciniphila, a Dedicated Intestinal Mucin Degrader, and Its Use in Exploring Intestinal Metagenomes". PLOS ONE. 6 (3) e16876. Bibcode:2011PLoSO...616876V. doi:10.1371/journal.pone.0016876. PMC 3048395. PMID 21390229.
Ajab SM, Zoughbor SH, Labania LA, et al. (2024). "Microbiota composition effect on immunotherapy outcomes in colorectal cancer patients: A systematic review". PLOS ONE. 19 (7) e0307639. Bibcode:2024PLoSO..1907639A. doi:10.1371/journal.pone.0307639. PMC 11268651. PMID 39047017.
Kim S, Lee Y, Kim Y, et al. (March 18, 2020). "Akkermansia muciniphila Prevents Fatty Liver Disease, Decreases Serum Triglycerides, and Maintains Gut Homeostasis". Applied and Environmental Microbiology. 86 (7): e03004–19. Bibcode:2020ApEnM..86E3004K. doi:10.1128/AEM.03004-19. PMC 7082569. PMID 31953338.

nature.com (Global: 234^th place; English: 397^th place)

Plovier H, Everard A, Druart C, et al. (January 2017). "A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice". Nature Medicine. 23 (1): 107–113. doi:10.1038/nm.4236. ISSN 1546-170X. PMID 27892954.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Zhang T, Li Q, Cheng L, et al. (November 2019). "Akkermansia muciniphila is a promising probiotic". Microbial Biotechnology. 12 (6): 1109–1125. doi:10.1111/1751-7915.13410. ISSN 1751-7915. PMC 6801136. PMID 31006995.
Derrien M (2004). "Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium". International Journal of Systematic and Evolutionary Microbiology. 54 (5): 1469–1476. doi:10.1099/ijs.0.02873-0. PMID 15388697.
de Vos W (2017). "Microbe Profile: Akkermansia muciniphila: a conserved intestinal symbiont that acts as the gatekeeper of our mucosa". Microbiology. 1635 (5): 646–648. doi:10.1099/mic.0.000444. PMID 28530168.
Everard A, Belzer C, Geurts L, et al. (May 28, 2013). "Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity". Proceedings of the National Academy of Sciences of the United States of America. 110 (22): 9066–9071. Bibcode:2013PNAS..110.9066E. doi:10.1073/pnas.1219451110. PMC 3670398. PMID 23671105.{{cite journal}}: CS1 maint: overridden setting (link)
Dao MC, Everard A, Aron-Wisnewsky J, et al. (March 2016). "Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology". Gut. 65 (3): 426–436. doi:10.1136/gutjnl-2014-308778. hdl:10044/1/24139. PMID 26100928.{{cite journal}}: CS1 maint: overridden setting (link)
Luo Y, Lan C, Li H, et al. (October 17, 2022). "Rational consideration of Akkermansia muciniphila targeting intestinal health: advantages and challenges". npj Biofilms and Microbiomes. 8 (1): 81. doi:10.1038/s41522-022-00338-4. ISSN 2055-5008. PMC 9576740. PMID 36253412.{{cite journal}}: CS1 maint: overridden setting (link)
Aggarwal V, Sunder S, Verma SR (December 1, 2022). "Disease-associated dysbiosis and potential therapeutic role of Akkermansia muciniphila, a mucus degrading bacteria of gut microbiome". Folia Microbiologica. 67 (6): 811–824. doi:10.1007/s12223-022-00973-6. ISSN 1874-9356. PMC 9122250. PMID 35596115.
Garcia-Vello P, Tytgat HL, Elzinga J, et al. (September 27, 2024). "The lipooligosaccharide of the gut symbiont Akkermansia muciniphila exhibits a remarkable structure and TLR signaling capacity". Nature Communications. 15 (1): 8411. Bibcode:2024NatCo..15.8411G. doi:10.1038/s41467-024-52683-x. ISSN 2041-1723. PMC 11436972. PMID 39333588.
Lerouge I, Vanderleyden J (March 1, 2002). "O-antigen structural variation: mechanisms and possible roles in animal/plant–microbe interactions". FEMS Microbiology Reviews. 26 (1): 17–47. doi:10.1111/j.1574-6976.2002.tb00597.x. ISSN 0168-6445. PMID 12007641.
Raimondi S, Musmeci E, Candeliere F, et al. (May 27, 2021). "Identification of mucin degraders of the human gut microbiota". Scientific Reports. 11 (1): 11094. Bibcode:2021NatSR..1111094R. doi:10.1038/s41598-021-90553-4. ISSN 2045-2322. PMC 8159939. PMID 34045537.
Marcus DM, Kabat EA, Schiffman G (March 1, 1964). "Immunochemical Studies on Blood Groups. XXXI. Destruction of Blood Group A Activity by an Enzyme from Clostridium tertium Which Deacetylates N-Acetylgalactosamine in Intact Blood Group Substances*". Biochemistry. 3 (3): 437–443. doi:10.1021/bi00891a023. ISSN 0006-2960. PMID 14158532.
Kamel M, Hanafi M, Bassiouni M (1991). "Inhibition of elastase enzyme release from human polymorphonuclear leukocytes by N-acetyl-galactosamine and N-acetyl-glucosamine". Clinical and Experimental Rheumatology. 9 (1): 17–21. ISSN 0392-856X. PMID 2054963.
Matsuura M (May 24, 2013). "Structural Modifications of Bacterial Lipopolysaccharide that Facilitate Gram-Negative Bacteria Evasion of Host Innate Immunity". Frontiers in Immunology. 4: 109. doi:10.3389/fimmu.2013.00109. ISSN 1664-3224. PMC 3662973. PMID 23745121.
Plovier H, Everard A, Druart C, et al. (January 2017). "A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice". Nature Medicine. 23 (1): 107–113. doi:10.1038/nm.4236. ISSN 1546-170X. PMID 27892954.
Bae M, Cassilly CD, Liu X, et al. (August 2022). "Akkermansia muciniphila phospholipid induces homeostatic immune responses". Nature. 608 (7921): 168–173. Bibcode:2022Natur.608..168B. doi:10.1038/s41586-022-04985-7. ISSN 1476-4687. PMC 9328018. PMID 35896748.
Ouwerkerk JP, van der Ark KC, Davids M, et al. (December 1, 2016). "Adaptation of Akkermansia muciniphila to the Oxic-Anoxic Interface of the Mucus Layer". Applied and Environmental Microbiology. 82 (23): 6983–6993. Bibcode:2016ApEnM..82.6983O. doi:10.1128/AEM.01641-16. PMC 5103097. PMID 27663027.
Shuoker B, Pichler MJ, Jin C, et al. (April 1, 2023). "Sialidases and fucosidases of Akkermansia muciniphila are crucial for growth on mucin and nutrient sharing with mucus-associated gut bacteria". Nature Communications. 14 (1): 1833. doi:10.1038/s41467-023-37533-6. ISSN 2041-1723. PMC 10067855. PMID 37005422.
van Passel MW, Kant R, Zoetendal EG, et al. (March 3, 2011). "The Genome of Akkermansia muciniphila, a Dedicated Intestinal Mucin Degrader, and Its Use in Exploring Intestinal Metagenomes". PLOS ONE. 6 (3) e16876. Bibcode:2011PLoSO...616876V. doi:10.1371/journal.pone.0016876. PMC 3048395. PMID 21390229.
Turck D, Bohn T, Castenmiller J, et al. (September 2021). "Safety of pasteurised Akkermansia muciniphila as a novel food pursuant to Regulation (EU) 2015/2283". EFSA Journal. 19 (9): e06780. doi:10.2903/j.efsa.2021.6780. PMC 8409316. PMID 34484452.
Davoutis E, Gkiafi Z, Lykoudis PM (May 16, 2024). "Bringing gut microbiota into the spotlight of clinical research and medical practice". World Journal of Clinical Cases. 12 (14): 2293–2300. doi:10.12998/wjcc.v12.i14.2293. PMC 11099419. PMID 38765739.
Zhou K (June 2017). "Strategies to promote abundance of Akkermansia muciniphila, an emerging probiotics in the gut, evidence from dietary intervention studies". Journal of Functional Foods. 33: 194–201. doi:10.1016/j.jff.2017.03.045. ISSN 1756-4646. PMC 6223323. PMID 30416539.
de Vos WM (2017). "Microbe Profile: Akkermansia muciniphila: a conserved intestinal symbiont that acts as the gatekeeper of our mucosa". Microbiology. 163 (5): 646–648. doi:10.1099/mic.0.000444. ISSN 1465-2080. PMID 28530168.
Tian R, Yu L, Tian F, et al. (May 7, 2024). "Effect of inulin, galacto-oligosaccharides, and polyphenols on the gut microbiota, with a focus on Akkermansia muciniphila". Food & Function. 15 (9): 4763–4772. doi:10.1039/d4fo00428k. ISSN 2042-650X. PMID 38590256.
Portincasa P, Khalil M, Graziani A, et al. (January 2024). "Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations? (Review)". European Journal of Internal Medicine. 119: 13–30. doi:10.1016/j.ejim.2023.10.002. PMID 37802720.
Ajab SM, Zoughbor SH, Labania LA, et al. (2024). "Microbiota composition effect on immunotherapy outcomes in colorectal cancer patients: A systematic review". PLOS ONE. 19 (7) e0307639. Bibcode:2024PLoSO..1907639A. doi:10.1371/journal.pone.0307639. PMC 11268651. PMID 39047017.
Gu ZY, Pei WL, Zhang Y, et al. (December 5, 2021). "Akkermansia muciniphila in inflammatory bowel disease and colorectal cancer". Chinese Medical Journal. 134 (23): 2841–2843. doi:10.1097/CM9.0000000000001829. ISSN 0366-6999. PMC 8667969. PMID 34711719.
Kim S, Lee Y, Kim Y, et al. (March 18, 2020). "Akkermansia muciniphila Prevents Fatty Liver Disease, Decreases Serum Triglycerides, and Maintains Gut Homeostasis". Applied and Environmental Microbiology. 86 (7): e03004–19. Bibcode:2020ApEnM..86E3004K. doi:10.1128/AEM.03004-19. PMC 7082569. PMID 31953338.

ncbi.nlm.nih.gov

Zhang T, Li Q, Cheng L, et al. (November 2019). "Akkermansia muciniphila is a promising probiotic". Microbial Biotechnology. 12 (6): 1109–1125. doi:10.1111/1751-7915.13410. ISSN 1751-7915. PMC 6801136. PMID 31006995.
Everard A, Belzer C, Geurts L, et al. (May 28, 2013). "Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity". Proceedings of the National Academy of Sciences of the United States of America. 110 (22): 9066–9071. Bibcode:2013PNAS..110.9066E. doi:10.1073/pnas.1219451110. PMC 3670398. PMID 23671105.{{cite journal}}: CS1 maint: overridden setting (link)
Luo Y, Lan C, Li H, et al. (October 17, 2022). "Rational consideration of Akkermansia muciniphila targeting intestinal health: advantages and challenges". npj Biofilms and Microbiomes. 8 (1): 81. doi:10.1038/s41522-022-00338-4. ISSN 2055-5008. PMC 9576740. PMID 36253412.{{cite journal}}: CS1 maint: overridden setting (link)
Aggarwal V, Sunder S, Verma SR (December 1, 2022). "Disease-associated dysbiosis and potential therapeutic role of Akkermansia muciniphila, a mucus degrading bacteria of gut microbiome". Folia Microbiologica. 67 (6): 811–824. doi:10.1007/s12223-022-00973-6. ISSN 1874-9356. PMC 9122250. PMID 35596115.
Garcia-Vello P, Tytgat HL, Elzinga J, et al. (September 27, 2024). "The lipooligosaccharide of the gut symbiont Akkermansia muciniphila exhibits a remarkable structure and TLR signaling capacity". Nature Communications. 15 (1): 8411. Bibcode:2024NatCo..15.8411G. doi:10.1038/s41467-024-52683-x. ISSN 2041-1723. PMC 11436972. PMID 39333588.
Raimondi S, Musmeci E, Candeliere F, et al. (May 27, 2021). "Identification of mucin degraders of the human gut microbiota". Scientific Reports. 11 (1): 11094. Bibcode:2021NatSR..1111094R. doi:10.1038/s41598-021-90553-4. ISSN 2045-2322. PMC 8159939. PMID 34045537.
Matsuura M (May 24, 2013). "Structural Modifications of Bacterial Lipopolysaccharide that Facilitate Gram-Negative Bacteria Evasion of Host Innate Immunity". Frontiers in Immunology. 4: 109. doi:10.3389/fimmu.2013.00109. ISSN 1664-3224. PMC 3662973. PMID 23745121.
Bae M, Cassilly CD, Liu X, et al. (August 2022). "Akkermansia muciniphila phospholipid induces homeostatic immune responses". Nature. 608 (7921): 168–173. Bibcode:2022Natur.608..168B. doi:10.1038/s41586-022-04985-7. ISSN 1476-4687. PMC 9328018. PMID 35896748.
Ouwerkerk JP, van der Ark KC, Davids M, et al. (December 1, 2016). "Adaptation of Akkermansia muciniphila to the Oxic-Anoxic Interface of the Mucus Layer". Applied and Environmental Microbiology. 82 (23): 6983–6993. Bibcode:2016ApEnM..82.6983O. doi:10.1128/AEM.01641-16. PMC 5103097. PMID 27663027.
Shuoker B, Pichler MJ, Jin C, et al. (April 1, 2023). "Sialidases and fucosidases of Akkermansia muciniphila are crucial for growth on mucin and nutrient sharing with mucus-associated gut bacteria". Nature Communications. 14 (1): 1833. doi:10.1038/s41467-023-37533-6. ISSN 2041-1723. PMC 10067855. PMID 37005422.
van Passel MW, Kant R, Zoetendal EG, et al. (March 3, 2011). "The Genome of Akkermansia muciniphila, a Dedicated Intestinal Mucin Degrader, and Its Use in Exploring Intestinal Metagenomes". PLOS ONE. 6 (3) e16876. Bibcode:2011PLoSO...616876V. doi:10.1371/journal.pone.0016876. PMC 3048395. PMID 21390229.
Turck D, Bohn T, Castenmiller J, et al. (September 2021). "Safety of pasteurised Akkermansia muciniphila as a novel food pursuant to Regulation (EU) 2015/2283". EFSA Journal. 19 (9): e06780. doi:10.2903/j.efsa.2021.6780. PMC 8409316. PMID 34484452.
Davoutis E, Gkiafi Z, Lykoudis PM (May 16, 2024). "Bringing gut microbiota into the spotlight of clinical research and medical practice". World Journal of Clinical Cases. 12 (14): 2293–2300. doi:10.12998/wjcc.v12.i14.2293. PMC 11099419. PMID 38765739.
Zhou K (June 2017). "Strategies to promote abundance of Akkermansia muciniphila, an emerging probiotics in the gut, evidence from dietary intervention studies". Journal of Functional Foods. 33: 194–201. doi:10.1016/j.jff.2017.03.045. ISSN 1756-4646. PMC 6223323. PMID 30416539.
Ajab SM, Zoughbor SH, Labania LA, et al. (2024). "Microbiota composition effect on immunotherapy outcomes in colorectal cancer patients: A systematic review". PLOS ONE. 19 (7) e0307639. Bibcode:2024PLoSO..1907639A. doi:10.1371/journal.pone.0307639. PMC 11268651. PMID 39047017.
Gu ZY, Pei WL, Zhang Y, et al. (December 5, 2021). "Akkermansia muciniphila in inflammatory bowel disease and colorectal cancer". Chinese Medical Journal. 134 (23): 2841–2843. doi:10.1097/CM9.0000000000001829. ISSN 0366-6999. PMC 8667969. PMID 34711719.
Kim S, Lee Y, Kim Y, et al. (March 18, 2020). "Akkermansia muciniphila Prevents Fatty Liver Disease, Decreases Serum Triglycerides, and Maintains Gut Homeostasis". Applied and Environmental Microbiology. 86 (7): e03004–19. Bibcode:2020ApEnM..86E3004K. doi:10.1128/AEM.03004-19. PMC 7082569. PMID 31953338.

oup.com (Global: 485^th place; English: 440^th place)

academic.oup.com

Lerouge I, Vanderleyden J (March 1, 2002). "O-antigen structural variation: mechanisms and possible roles in animal/plant–microbe interactions". FEMS Microbiology Reviews. 26 (1): 17–47. doi:10.1111/j.1574-6976.2002.tb00597.x. ISSN 0168-6445. PMID 12007641.

pendulumlife.com (Global: low place; English: low place)

"Akkermansia". Pendulum. Retrieved April 3, 2025.

worldcat.org (Global: 5^th place; English: 5^th place)

search.worldcat.org

Zhang T, Li Q, Cheng L, et al. (November 2019). "Akkermansia muciniphila is a promising probiotic". Microbial Biotechnology. 12 (6): 1109–1125. doi:10.1111/1751-7915.13410. ISSN 1751-7915. PMC 6801136. PMID 31006995.
Luo Y, Lan C, Li H, et al. (October 17, 2022). "Rational consideration of Akkermansia muciniphila targeting intestinal health: advantages and challenges". npj Biofilms and Microbiomes. 8 (1): 81. doi:10.1038/s41522-022-00338-4. ISSN 2055-5008. PMC 9576740. PMID 36253412.{{cite journal}}: CS1 maint: overridden setting (link)
Aggarwal V, Sunder S, Verma SR (December 1, 2022). "Disease-associated dysbiosis and potential therapeutic role of Akkermansia muciniphila, a mucus degrading bacteria of gut microbiome". Folia Microbiologica. 67 (6): 811–824. doi:10.1007/s12223-022-00973-6. ISSN 1874-9356. PMC 9122250. PMID 35596115.
Garcia-Vello P, Tytgat HL, Elzinga J, et al. (September 27, 2024). "The lipooligosaccharide of the gut symbiont Akkermansia muciniphila exhibits a remarkable structure and TLR signaling capacity". Nature Communications. 15 (1): 8411. Bibcode:2024NatCo..15.8411G. doi:10.1038/s41467-024-52683-x. ISSN 2041-1723. PMC 11436972. PMID 39333588.
Lerouge I, Vanderleyden J (March 1, 2002). "O-antigen structural variation: mechanisms and possible roles in animal/plant–microbe interactions". FEMS Microbiology Reviews. 26 (1): 17–47. doi:10.1111/j.1574-6976.2002.tb00597.x. ISSN 0168-6445. PMID 12007641.
Raimondi S, Musmeci E, Candeliere F, et al. (May 27, 2021). "Identification of mucin degraders of the human gut microbiota". Scientific Reports. 11 (1): 11094. Bibcode:2021NatSR..1111094R. doi:10.1038/s41598-021-90553-4. ISSN 2045-2322. PMC 8159939. PMID 34045537.
Marcus DM, Kabat EA, Schiffman G (March 1, 1964). "Immunochemical Studies on Blood Groups. XXXI. Destruction of Blood Group A Activity by an Enzyme from Clostridium tertium Which Deacetylates N-Acetylgalactosamine in Intact Blood Group Substances*". Biochemistry. 3 (3): 437–443. doi:10.1021/bi00891a023. ISSN 0006-2960. PMID 14158532.
Kamel M, Hanafi M, Bassiouni M (1991). "Inhibition of elastase enzyme release from human polymorphonuclear leukocytes by N-acetyl-galactosamine and N-acetyl-glucosamine". Clinical and Experimental Rheumatology. 9 (1): 17–21. ISSN 0392-856X. PMID 2054963.
Matsuura M (May 24, 2013). "Structural Modifications of Bacterial Lipopolysaccharide that Facilitate Gram-Negative Bacteria Evasion of Host Innate Immunity". Frontiers in Immunology. 4: 109. doi:10.3389/fimmu.2013.00109. ISSN 1664-3224. PMC 3662973. PMID 23745121.
Plovier H, Everard A, Druart C, et al. (January 2017). "A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice". Nature Medicine. 23 (1): 107–113. doi:10.1038/nm.4236. ISSN 1546-170X. PMID 27892954.
Bae M, Cassilly CD, Liu X, et al. (August 2022). "Akkermansia muciniphila phospholipid induces homeostatic immune responses". Nature. 608 (7921): 168–173. Bibcode:2022Natur.608..168B. doi:10.1038/s41586-022-04985-7. ISSN 1476-4687. PMC 9328018. PMID 35896748.
Iwaza R, Wasfy RM, Dubourg G, et al. (2022). "Akkermansia muciniphila: The state of the art, 18 years after its first discovery". Frontiers in Gastroenterology. 1 1024393. doi:10.3389/fgstr.2022.1024393. ISSN 2813-1169.
Shuoker B, Pichler MJ, Jin C, et al. (April 1, 2023). "Sialidases and fucosidases of Akkermansia muciniphila are crucial for growth on mucin and nutrient sharing with mucus-associated gut bacteria". Nature Communications. 14 (1): 1833. doi:10.1038/s41467-023-37533-6. ISSN 2041-1723. PMC 10067855. PMID 37005422.
Zhou K (June 2017). "Strategies to promote abundance of Akkermansia muciniphila, an emerging probiotics in the gut, evidence from dietary intervention studies". Journal of Functional Foods. 33: 194–201. doi:10.1016/j.jff.2017.03.045. ISSN 1756-4646. PMC 6223323. PMID 30416539.
de Vos WM (2017). "Microbe Profile: Akkermansia muciniphila: a conserved intestinal symbiont that acts as the gatekeeper of our mucosa". Microbiology. 163 (5): 646–648. doi:10.1099/mic.0.000444. ISSN 1465-2080. PMID 28530168.
Tian R, Yu L, Tian F, et al. (May 7, 2024). "Effect of inulin, galacto-oligosaccharides, and polyphenols on the gut microbiota, with a focus on Akkermansia muciniphila". Food & Function. 15 (9): 4763–4772. doi:10.1039/d4fo00428k. ISSN 2042-650X. PMID 38590256.
Gu ZY, Pei WL, Zhang Y, et al. (December 5, 2021). "Akkermansia muciniphila in inflammatory bowel disease and colorectal cancer". Chinese Medical Journal. 134 (23): 2841–2843. doi:10.1097/CM9.0000000000001829. ISSN 0366-6999. PMC 8667969. PMID 34711719.